메뉴 건너뛰기




Volumn 5, Issue 4, 2005, Pages 537-544

Advances in allergen-specific immunotherapy

Author keywords

Allergy; Immunological mechanisms; Immunotherapy; Treg; Th1; Th2; Vaccination

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BCG VACCINE; BET V 1 ALLERGEN; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DER P 1 ALLERGEN; DER P 2 ALLERGEN; DNA VACCINE; HOUSE DUST ALLERGEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OLIGONUCLEOTIDE; PEPTIDE; PHOSPHORYL LIPID A; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

EID: 17844394969     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.5.4.537     Document Type: Review
Times cited : (7)

References (75)
  • 1
    • 50249230114 scopus 로고
    • Prophylactic inoculation against hay fever
    • NOON L, CANTAB BC: Prophylactic inoculation against hay fever. Lancet (1911) 177:1572-1573.
    • (1911) Lancet , vol.177 , pp. 1572-1573
    • Noon, L.1    Cantab, B.C.2
  • 2
    • 0029820287 scopus 로고    scopus 로고
    • Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro
    • AKDIS CA, AKDIS M, BLESKEN T et al.: Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. (1996) 98:1676-1683.
    • (1996) J. Clin. Invest. , vol.98 , pp. 1676-1683
    • Akdis, C.A.1    Akdis, M.2    Blesken, T.3
  • 3
    • 4644360689 scopus 로고    scopus 로고
    • T regulatory cells in allergy and health: A question of allergen specificity and balance
    • TAYLOR A, VERHAGEN J, AKDIS CA, AKDIS M: T regulatory cells in allergy and health: a question of allergen specificity and balance. Int. Arch. Allergy Immunol. (2004) 135:73-82.
    • (2004) Int. Arch. Allergy Immunol. , vol.135 , pp. 73-82
    • Taylor, A.1    Verhagen, J.2    Akdis, C.A.3    Akdis, M.4
  • 5
    • 0032524991 scopus 로고    scopus 로고
    • Transplacental priming of the human immune system to environmental allergens: Universal skewing of initial T cell responses toward the Th2 cytokine profile
    • PRESCOTT SL, MACAUBAS C, HOLT BJ et al.: Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J. Immunol. (1998) 160:4730-4737.
    • (1998) J. Immunol. , vol.160 , pp. 4730-4737
    • Prescott, S.L.1    Macaubas, C.2    Holt, B.J.3
  • 7
    • 0033961847 scopus 로고    scopus 로고
    • Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases
    • YSSEL H, GROUX H: Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int. Arch. Allergy Immunol. (2000) 121:10-18.
    • (2000) Int. Arch. Allergy Immunol. , vol.121 , pp. 10-18
    • Yssel, H.1    Groux, H.2
  • 8
    • 0033932896 scopus 로고    scopus 로고
    • T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis
    • TRAUTMANN A, AKDIS M, KLEEMANN D et al.: T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. (2000) 106:25-35.
    • (2000) J. Clin. Invest. , vol.106 , pp. 25-35
    • Trautmann, A.1    Akdis, M.2    Kleemann, D.3
  • 10
    • 0038387249 scopus 로고    scopus 로고
    • T helper (Th) 2 predominance in atopic disease is due to preferential apoptosis of circulating memory/effector Th1 cells
    • AKDIS M, TRAUTMANN A, KLUNKER S et al.: T helper (Th) 2 predominance in atopic disease is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J. (2003) 17:1026-1035.
    • (2003) FASEB J. , vol.17 , pp. 1026-1035
    • Akdis, M.1    Trautmann, A.2    Klunker, S.3
  • 11
    • 0028288179 scopus 로고
    • Lymphokine production by human T cells in disease states
    • ROMAGNANI S: Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. (1994) 12:227-257.
    • (1994) Annu. Rev. Immunol. , vol.12 , pp. 227-257
    • Romagnani, S.1
  • 12
    • 0032749783 scopus 로고    scopus 로고
    • IL-13 in allergy: Home at last
    • CORRY DB: IL-13 in allergy: home at last. Curr. Opin. Immunol. (1999) 11:610-614.
    • (1999) Curr. Opin. Immunol. , vol.11 , pp. 610-614
    • Corry, D.B.1
  • 13
    • 0036240589 scopus 로고    scopus 로고
    • Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System
    • MOVERARE R, ELFMAN L, VESTERINEN E, METSO T, HAAHTELA T: Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy (2002) 57:423-430.
    • (2002) Allergy , vol.57 , pp. 423-430
    • Moverare, R.1    Elfman, L.2    Vesterinen, E.3    Metso, T.4    Haahtela, T.5
  • 14
    • 2442648797 scopus 로고    scopus 로고
    • Allergen immunotherapy: Therapeutic vaccines for allergic diseases
    • World Health Organization. American Academy of Allergy, Asthma and Immunology
    • BOUSQUET J, LOCKEY R, MALLING HJ et al.: Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. (1998) 81:401-405.
    • (1998) Ann. Allergy Asthma Immunol. , vol.81 , pp. 401-405
    • Bousquet, J.1    Lockey, R.2    Malling, H.J.3
  • 15
    • 0038603844 scopus 로고    scopus 로고
    • Peptide immunotherapy for allergic disease
    • TARZI M, LARCHE M: Peptide immunotherapy for allergic disease. Expert Opin. Biol. Ther. (2003) 3:617-626.
    • (2003) Expert Opin. Biol. Ther. , vol.3 , pp. 617-626
    • Tarzi, M.1    Larche, M.2
  • 16
    • 0034665515 scopus 로고    scopus 로고
    • Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice
    • ASTORI M, VON GARNIER C, KETTNER A, DUFOUR N, CORRADIN G, SPERTINI F: Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. J. Immunol. (2000) 165:3497-3505.
    • (2000) J. Immunol. , vol.165 , pp. 3497-3505
    • Astori, M.1    Von Garnier, C.2    Kettner, A.3    Dufour, N.4    Corradin, G.5    Spertini, F.6
  • 17
    • 0035462111 scopus 로고    scopus 로고
    • Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1
    • VRTALA S, HIRTENLEHNER K, SUSANI M et al.: Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J. (2001) 15:2045-2047. Single amino acid mutations in recombinant allergens lead to hypoallergic variants by altering IgE epitopes.
    • (2001) FASEB J. , vol.15 , pp. 2045-2047
    • Vrtala, S.1    Hirtenlehner, K.2    Susani, M.3
  • 18
    • 0034544450 scopus 로고    scopus 로고
    • T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen. Bet v 1, induce blocking antibodies
    • VRTALA S, AKDIS CA, BUDAK F et al.: T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen. Bet v 1, induce blocking antibodies. J. Immunol. (2000) 165:6653-6659.
    • (2000) J. Immunol. , vol.165 , pp. 6653-6659
    • Vrtala, S.1    Akdis, C.A.2    Budak, F.3
  • 19
    • 0036676925 scopus 로고    scopus 로고
    • Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity
    • LINHART B, JAHN-SCHMID B, VERDINO P et al.: Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity. FASEB J. (2002) 16:1301-1303.
    • (2002) FASEB J. , vol.16 , pp. 1301-1303
    • Linhart, B.1    Jahn-Schmid, B.2    Verdino, P.3
  • 20
    • 0031952580 scopus 로고    scopus 로고
    • Modulation of IgE reactivity of allergens by site-directed mutagenesis: Potential use of hypoallergenic variants for immunotherapy
    • FERREIRA F, EBNER C, KRAMER B et al.: Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J. (1998) 12:231-242.
    • (1998) FASEB J. , vol.12 , pp. 231-242
    • Ferreira, F.1    Ebner, C.2    Kramer, B.3
  • 21
    • 0031866059 scopus 로고    scopus 로고
    • Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
    • MULLER U, AKDIS CA, FRICKER M et al.: Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. (1998) 101:747-754. This is the first human short T cell epitope peptide immunotherapy, which shows allergen-specific T cell tolerance and regulation of IgG4 versus IgE ratios in favour of IgG4 1 week after contact with live bee stings.
    • (1998) J. Allergy Clin. Immunol. , vol.101 , pp. 747-754
    • Muller, U.1    Akdis, C.A.2    Fricker, M.3
  • 22
    • 0032783475 scopus 로고    scopus 로고
    • B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy
    • BALL T, FUCHS T, SPERR WR et al.: B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy. FASEB J. (1999) 13:1277-1290.
    • (1999) FASEB J. , vol.13 , pp. 1277-1290
    • Ball, T.1    Fuchs, T.2    Sperr, W.R.3
  • 23
    • 0026579897 scopus 로고
    • Genetic immunization is a simple method for eliciting an immune response
    • TANG DC, DEVIT M, JOHNSTON SA: Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 356:152-154.
    • (1992) Nature , vol.356 , pp. 152-154
    • Tang, D.C.1    Devit, M.2    Johnston, S.A.3
  • 24
    • 0029664297 scopus 로고    scopus 로고
    • Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
    • RAZ E, TIGHE H, SATO Y et al.: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA (1996) 93:5141-5145.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 5141-5145
    • Raz, E.1    Tighe, H.2    Sato, Y.3
  • 25
    • 0029925502 scopus 로고    scopus 로고
    • Immunoprophylaxis of allergen-induced immunoglobulin e synthesis and airway hyperresponsiveness in vivo by genetic immunization
    • HSU CH, CHUA KY, TAO MH et al.: Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat. Med. (1996) 2:540-544.
    • (1996) Nat. Med. , vol.2 , pp. 540-544
    • Hsu, C.H.1    Chua, K.Y.2    Tao, M.H.3
  • 26
    • 0032944136 scopus 로고    scopus 로고
    • Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen
    • HARTL A, KIESSLICH J, WEISS R et al.: Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J. Allergy Clin. Immunol. (1999) 103:107-113.
    • (1999) J. Allergy Clin. Immunol. , vol.103 , pp. 107-113
    • Hartl, A.1    Kiesslich, J.2    Weiss, R.3
  • 27
    • 0034919063 scopus 로고    scopus 로고
    • The effect of vaccination with DNA encoding murine T-cell epitopes on the der p 1 and 2 induced imnmnoglobulin e synthesis
    • KWON SS, KIM N, YOO TJ: The effect of vaccination with DNA encoding murine T-cell epitopes on the Der p 1 and 2 induced imnmnoglobulin E synthesis. Allergy (2001) 56:741-748.
    • (2001) Allergy , vol.56 , pp. 741-748
    • Kwon, S.S.1    Kim, N.2    Yoo, T.J.3
  • 28
    • 0031716080 scopus 로고    scopus 로고
    • The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine
    • SLATER JE, PAUPORE E, ZHANG YT, COLBERG-POLEY AM: The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine. J. Allergy Clin. Immunol. (1998) 102:469-475.
    • (1998) J. Allergy Clin. Immunol. , vol.102 , pp. 469-475
    • Slater, J.E.1    Paupore, E.2    Zhang, Y.T.3    Colberg-Poley, A.M.4
  • 29
    • 0000839580 scopus 로고
    • The oral administration of pollen
    • BLACK J: The oral administration of pollen. J. Lab. Clin. Med. (1927) 12:1156.
    • (1927) J. Lab. Clin. Med. , vol.12 , pp. 1156
    • Black, J.1
  • 30
    • 0037340480 scopus 로고    scopus 로고
    • Noninjection routes for immunotherapy
    • CANONICA GW, PASSALACQUA G: Noninjection routes for immunotherapy. J. Allergy Clin. Immunol. (2003) 111:437-448. A comprehensive review of non-injection imunotherapy.
    • (2003) J. Allergy Clin. Immunol. , vol.111 , pp. 437-448
    • Canonica, G.W.1    Passalacqua, G.2
  • 31
    • 0026822349 scopus 로고
    • Immunotherapy by inhalation of allergen in powder in house dust allergic asthma - A double-blind study
    • TARI MG, MANCINO M, MONTI G: Immunotherapy by inhalation of allergen in powder in house dust allergic asthma-a double-blind study. J. Investig. Allergol. Clin. Immunol. (1992) 2:59-67.
    • (1992) J. Investig. Allergol. Clin. Immunol. , vol.2 , pp. 59-67
    • Tari, M.G.1    Mancino, M.2    Monti, G.3
  • 32
    • 0025909578 scopus 로고
    • Local immnnotherapy with Dermatophagoides extract in asthma
    • CRIMI E, VOLTOLINI S, TROISE C et al.: Local immnnotherapy with Dermatophagoides extract in asthma. J. Allergy Clin. Immunol. (1991) 87:721-728.
    • (1991) J. Allergy Clin. Immunol. , vol.87 , pp. 721-728
    • Crimi, E.1    Voltolini, S.2    Troise, C.3
  • 33
    • 0036959080 scopus 로고    scopus 로고
    • Is sublingual immunotherapy clinically effective?
    • MALLING HJ: Is sublingual immunotherapy clinically effective? Curr. Opin. Allergy Clin. Immunol. (2002) 2:523-531.
    • (2002) Curr. Opin. Allergy Clin. Immunol. , vol.2 , pp. 523-531
    • Malling, H.J.1
  • 35
    • 16444365595 scopus 로고    scopus 로고
    • Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mite
    • BAHCECILER NN, ARIKAN C, TAYLOR A et al.: Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mite. Int. Arch. Allergy Immunol. (2005) 136(3):287-294.
    • (2005) Int. Arch. Allergy Immunol. , vol.136 , Issue.3 , pp. 287-294
    • Bahceciler, N.N.1    Arikan, C.2    Taylor, A.3
  • 36
    • 0037833502 scopus 로고    scopus 로고
    • Immunomodulation during sublingual therapy in allergic children
    • IPPOLITI F, DE SANTIS W, VOLTERRANI A et al.: Immunomodulation during sublingual therapy in allergic children. Pediatr. Allergy Immunol. (2003) 14:216-221.
    • (2003) Pediatr. Allergy Immunol. , vol.14 , pp. 216-221
    • Ippoliti, F.1    De Santis, W.2    Volterrani, A.3
  • 37
    • 1642290976 scopus 로고    scopus 로고
    • Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy
    • ARIKAN C, BAHCECILER NN, DENIZ G et al.: Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin. Exp. Allergy (2004) 34:398-405. This study demonstrates that BCG vaccine administered together with SLIT induces IL-12 production, without improving clinical outcome.
    • (2004) Clin. Exp. Allergy , vol.34 , pp. 398-405
    • Arikan, C.1    Bahceciler, N.N.2    Deniz, G.3
  • 38
    • 0031914629 scopus 로고    scopus 로고
    • Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae
    • WANG CC, ROOK GA: Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology (1998) 93:307-313.
    • (1998) Immunology , vol.93 , pp. 307-313
    • Wang, C.C.1    Rook, G.A.2
  • 39
    • 0036278230 scopus 로고    scopus 로고
    • Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells
    • ZUANY-AMORIM C, SAWICKA E, MANLIUS C et al.: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. (2002) 8:625-629.
    • (2002) Nat. Med. , vol.8 , pp. 625-629
    • Zuany-Amorim, C.1    Sawicka, E.2    Manlius, C.3
  • 40
    • 0242303573 scopus 로고    scopus 로고
    • Inhibition of T helper 2-type responses, IgF, production and eosinophilia by synthetic lipopeptides
    • AKDIS CA, KUSSEBI F, PULENDRAN B et al.: Inhibition of T helper 2-type responses, IgF, production and eosinophilia by synthetic lipopeptides. Eur. J. Immunol. (2003) 33:2717-2726. TLR2-triggering immunostimulatory lipopeptides suppress IgE and lung eosinophilia, and induce IFN-γ and IL-10 production by T cells.
    • (2003) Eur. J. Immunol. , vol.33 , pp. 2717-2726
    • Akdis, C.A.1    Kussebi, F.2    Pulendran, B.3
  • 41
    • 2442681742 scopus 로고    scopus 로고
    • A novel approach to specific allergy treatment: The recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity
    • BOHLE B, BREITWIESER A, ZWOLFER B et al.: A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity. J. Immunol. (2004) 172:6642-6648.
    • (2004) J. Immunol. , vol.172 , pp. 6642-6648
    • Bohle, B.1    Breitwieser, A.2    Zwolfer, B.3
  • 42
    • 3042718066 scopus 로고    scopus 로고
    • Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA
    • SIMONS FE, SHIKISHIMA Y, VAN NEST G, EIDEN JJ, HAYGLASS KT: Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J. Allergy Clin. Immunol. (2004) 113:1 144-1151. Amb a 1-immunostimulatory DNA sequence conjugate SIT led to a prolonged shift from Th2 immunity towards Th1 immunity and appeared to be safe.
    • (2004) J. Allergy Clin. Immunol. , vol.113 , pp. 1144-1151
    • Simons, F.E.1    Shikishima, Y.2    Van Nest, G.3    Eiden, J.J.4    Hayglass, K.T.5
  • 43
    • 1842631153 scopus 로고    scopus 로고
    • Immunotherapeutic uses of CpG oligodeoxynucleotides
    • KLINMAN DM: Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. (2004) 4:249-258.
    • (2004) Nat. Rev. Immunol. , vol.4 , pp. 249-258
    • Klinman, D.M.1
  • 44
    • 0032921181 scopus 로고    scopus 로고
    • IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy
    • AKDIS CA, BLASER K: IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J. (1999) 13:603-609.
    • (1999) FASEB J. , vol.13 , pp. 603-609
    • Akdis, C.A.1    Blaser, K.2
  • 45
    • 0032128421 scopus 로고    scopus 로고
    • Role of IL-10 in specific immunotherapy
    • AKDIS CA, BLESKEN T, AKDIS M, WÜTHRICH B, BLASER K: Role of IL-10 in specific immunotherapy. J. Clin. Invest. (1998) 102:98-106. This study shows that IL-10 plays a major role in T cell unresponsiveness.
    • (1998) J. Clin. Invest. , vol.102 , pp. 98-106
    • Akdis, C.A.1    Blesken, T.2    Akdis, M.3    Wüthrich, B.4    Blaser, K.5
  • 46
    • 0038363534 scopus 로고    scopus 로고
    • IL-10 and TGF-β cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
    • JUTEL M, AKDIS M, BUDAK F et al.: IL-10 and TGF-β cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. (2003) 33:1205-1214.
    • (2003) Eur. J. Immunol. , vol.33 , pp. 1205-1214
    • Jutel, M.1    Akdis, M.2    Budak, F.3
  • 47
    • 0029013533 scopus 로고
    • Grass pollen immunotherapy: Efficacy and safety during a 4-year follow- up study
    • WALKER SM, VARNEY VA, GAGA M, JACOBSON MR, DURHAM SR: Grass pollen immunotherapy: efficacy and safety during a 4-year follow- up study. Allergy (1995) 50:405-413.
    • (1995) Allergy , vol.50 , pp. 405-413
    • Walker, S.M.1    Varney, V.A.2    Gaga, M.3    Jacobson, M.R.4    Durham, S.R.5
  • 48
    • 0025979907 scopus 로고
    • Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs
    • VARNEY VA, GAGA M, FREW AJ, ABER VR, KAY AB, DURHAM SR: Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Br. Med. J. (1991) 302:265-269.
    • (1991) Br. Med. J. , vol.302 , pp. 265-269
    • Varney, V.A.1    Gaga, M.2    Frew, A.J.3    Aber, V.R.4    Kay, A.B.5    Durham, S.R.6
  • 49
    • 0018875627 scopus 로고
    • Generation of antigen-specific suppressor cells during allergy desensitization
    • ROCKLIN RE, SHEFFER AL, GREINEDER DK, MELMON KL: Generation of antigen-specific suppressor cells during allergy desensitization. N. Engl. J. Med. (1980) 302:1213-1219.
    • (1980) N. Engl. J. Med. , vol.302 , pp. 1213-1219
    • Rocklin, R.E.1    Sheffer, A.L.2    Greineder, D.K.3    Melmon, K.L.4
  • 50
    • 0022337169 scopus 로고
    • Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy
    • CRETICOS PS, ADKINSON NF JR, KAGEY-SOBOTKA A et al.: Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J. Clin. Invest. (1985) 76:2247-2253.
    • (1985) J. Clin. Invest. , vol.76 , pp. 2247-2253
    • Creticos, P.S.1    Adkinson Jr., N.F.2    Kagey-Sobotka, A.3
  • 51
    • 0023722274 scopus 로고
    • The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients
    • RAK S, LOWHAGEN O, VENGE P: The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J. Allergy Clin. Immunol. (1988) 82:470-480.
    • (1988) J. Allergy Clin. Immunol. , vol.82 , pp. 470-480
    • Rak, S.1    Lowhagen, O.2    Venge, P.3
  • 53
    • 0036687715 scopus 로고    scopus 로고
    • Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody
    • FLICKER S, STEINBERGER P, NORDERHAUG L et al.: Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody. Eur. J. Immunol. (2002) 32:2156-2162.
    • (2002) Eur. J. Immunol. , vol.32 , pp. 2156-2162
    • Flicker, S.1    Steinberger, P.2    Norderhaug, L.3
  • 54
    • 0033197966 scopus 로고    scopus 로고
    • Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgF-facilitated allergen presentation
    • VAN NEERVEN RJ, WIKBORG T, LUND G et al.: Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgF-facilitated allergen presentation. J. Immunol. (1999) 163:2944-2952.
    • (1999) J. Immunol. , vol.163 , pp. 2944-2952
    • Van Neerven, R.J.1    Wikborg, T.2    Lund, G.3
  • 55
    • 0038363534 scopus 로고    scopus 로고
    • IL-10 and TGE-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
    • JUTEL M, AKDIS M, BUDAK F et al.: IL-10 and TGE-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. (2003) 33:1205-1214.
    • (2003) Eur. J. Immunol. , vol.33 , pp. 1205-1214
    • Jutel, M.1    Akdis, M.2    Budak, F.3
  • 57
    • 2942685507 scopus 로고    scopus 로고
    • Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
    • AKDIS M, VERHAGEN J, TAYLOR A et al.: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. (2004) 199:1567-1575. One of the key issues in monoallergies is to understand why an individual develops an allergy to a single protein, while tolerating thousands of others. Tr1 cells consistently represent the dominant subset specific for common environmental allergens in healthy individuals; in contrast, there is a high frequency of allergen-specific Th2 cells in allergic individuals.
    • (2004) J. Exp. Med. , vol.199 , pp. 1567-1575
    • Akdis, M.1    Verhagen, J.2    Taylor, A.3
  • 59
    • 0031150153 scopus 로고    scopus 로고
    • T cells subsets and cytokines in allergic and non-allergic children. 11. Analysis and IL-5 and IL-10 mRNA expression and protein production
    • KONING H, NEIJENS HJ, BAERT MR, ORANJE AP, SAVELKOUL HF: T cells subsets and cytokines in allergic and non-allergic children. 11. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine (1997) 9:427-436.
    • (1997) Cytokine , vol.9 , pp. 427-436
    • Koning, H.1    Neijens, H.J.2    Baert, M.R.3    Oranje, A.P.4    Savelkoul, H.F.5
  • 60
    • 0036177295 scopus 로고    scopus 로고
    • Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice
    • HELLINGS PW, VANDENBERGHE P, KASRAN A et al.: Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur. J. Immunol. (2002) 32:585-594.
    • (2002) Eur. J. Immunol. , vol.32 , pp. 585-594
    • Hellings, P.W.1    Vandenberghe, P.2    Kasran, A.3
  • 61
    • 0033172973 scopus 로고    scopus 로고
    • Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high- dose tolerance in the trachea
    • HANEDA K, SANO K, TAMURA G et al.: Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high- dose tolerance in the trachea. Am. J. Respir. Cell Mol. Biol. (1999) 21:268-274.
    • (1999) Am. J. Respir. Cell Mol. Biol. , vol.21 , pp. 268-274
    • Haneda, K.1    Sano, K.2    Tamura, G.3
  • 63
    • 0024445451 scopus 로고
    • Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production
    • SONODA E, MATSUMOTO R, HITOSHI Y et al.: Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. (1989) 170:1415-1420.
    • (1989) J. Exp. Med. , vol.170 , pp. 1415-1420
    • Sonoda, E.1    Matsumoto, R.2    Hitoshi, Y.3
  • 65
    • 0004445079 scopus 로고
    • Low-affinity IgE receptor (CD23) function on mouse B cells: Role in IgE-dependent antigen focusing
    • KEHRY MR, YAMASHITA LC: Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc. Natl. Acad. Sci. USA (1989) 86:7556-7560.
    • (1989) Proc. Natl. Acad. Sci. USA , vol.86 , pp. 7556-7560
    • Kehry, M.R.1    Yamashita, L.C.2
  • 66
    • 0030991751 scopus 로고
    • Effect of transmembrane and cytoplasmic domains of IgE on the IgE response
    • ACHATZ G, NITSCHKE L, LAMERS MC: Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. Science (1977) 276:409-411.
    • (1977) Science , vol.276 , pp. 409-411
    • Achatz, G.1    Nitschke, L.2    Lamers, M.C.3
  • 67
    • 4644265623 scopus 로고    scopus 로고
    • Transforming growth factor-beta 1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro
    • ALLAM JP, KLEIN E, BIEBER T, NOVAK N: Transforming growth factor-beta 1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro. J. Invest. Dermatol. (2004) 123:676-682.
    • (2004) J. Invest. Dermatol. , vol.123 , pp. 676-682
    • Allam, J.P.1    Klein, E.2    Bieber, T.3    Novak, N.4
  • 68
    • 9844241585 scopus 로고    scopus 로고
    • IgE responses to Dermatophagoides pteronyssinus native major allergens der p 1 and der p 2 during long-term specific immunotherapy
    • MASTRANDREA F, SERIO G, MINARDI A et al.: IgE responses to Dermatophagoides pteronyssinus native major allergens Der p 1 and Der p 2 during long-term specific immunotherapy. Allergy (1997) 52:1115-1119.
    • (1997) Allergy , vol.52 , pp. 1115-1119
    • Mastrandrea, F.1    Serio, G.2    Minardi, A.3
  • 69
    • 0035103661 scopus 로고    scopus 로고
    • Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: Significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity
    • PICHLER CE, HELBLING A, PICHLER WJ: Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy (2001) 56:301-306.
    • (2001) Allergy , vol.56 , pp. 301-306
    • Pichler, C.E.1    Helbling, A.2    Pichler, W.J.3
  • 70
    • 0025805857 scopus 로고
    • T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma
    • WALKER C, VIRCHOW JC JR, BRUIJNZEEL PL, BLASER K: T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. (1991) 146:1829-1835.
    • (1991) J. Immunol. , vol.146 , pp. 1829-1835
    • Walker, C.1    Virchow Jr., J.C.2    Bruijnzeel, P.L.3    Blaser, K.4
  • 71
    • 0024323445 scopus 로고
    • Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids
    • SCHLEIMER RP, DERSE CP, FRIEDMAN B et al.: Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids. J. Immunol. (1989) 143:1310-1327.
    • (1989) J. Immunol. , vol.143 , pp. 1310-1327
    • Schleimer, R.P.1    Derse, C.P.2    Friedman, B.3
  • 72
    • 0034671063 scopus 로고    scopus 로고
    • Antigen-specific T cell tolerance down-regulates mast cell responses in vivo
    • TRETER S, LUQMAN M: Antigen-specific T cell tolerance down-regulates mast cell responses in vivo. Cell. Immunol. (2000) 206:116-124.
    • (2000) Cell. Immunol. , vol.206 , pp. 116-124
    • Treter, S.1    Luqman, M.2
  • 73
    • 1142265867 scopus 로고    scopus 로고
    • Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability
    • SHIM YK, KIM BS, CHO SH, MIN KU, HONG SJ: Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability. Clin. Exp. Allergy (2003) 33:52-57.
    • (2003) Clin. Exp. Allergy , vol.33 , pp. 52-57
    • Shim, Y.K.1    Kim, B.S.2    Cho, S.H.3    Min, K.U.4    Hong, S.J.5
  • 74
    • 0030025471 scopus 로고    scopus 로고
    • Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells
    • MARSHALL JS, LEAL-BERUMEN I, NIELSEN L, GLIBETIC M, JORDANA M: Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. (1996) 97:1122-1128.
    • (1996) J. Clin. Invest. , vol.97 , pp. 1122-1128
    • Marshall, J.S.1    Leal-Berumen, I.2    Nielsen, L.3    Glibetic, M.4    Jordana, M.5
  • 75
    • 0028181890 scopus 로고
    • B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10
    • SCHANDANE L, ALONSO-VEGA C, WILLEMS F et al.: B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. (1994) 152:4368-4374.
    • (1994) J. Immunol. , vol.152 , pp. 4368-4374
    • Schandane, L.1    Alonso-Vega, C.2    Willems, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.